Bridging Innate and Adaptive Antitumor Immunity Targeting Glycans

<table>A. ELISA plates were coated with blood type B antigen and reactivity of Gal purified human antibodies detected. Human IVIg was used as control.</table>

BioMed Research International

fig1

Figure 1

Figure 1: Bridging Innate and Adaptive Antitumor Immunity Targeting Glycans 